CVS Health Corporation/ US1266501006 /
| 08/11/2024 22:10:00 | Chg. -1.53 | Volume | Bid02:00:00 | Ask02:00:00 | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 55.54USD | -2.68% | 13.65 mill. Turnover: 592.84 mill. |
55.60Bid Size: 300 | 55.90Ask Size: 100 | 69.89 bill.USD | 4.36% | 8.56 |
Assets
|
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 12,044 | 12,606 | 12,896 | 12,873 | 13,183 | ||||||
| Intangible Assets | 33,121 | 31,142 | 29,026 | 24,754 | 29,234 | ||||||
| Long-Term Investments | 17,314 | 20,812 | 23,025 | 21,096 | 23,019 | ||||||
| Fixed Assets | 172,147 | 174,346 | 172,991 | 162,593 | 181,870 | ||||||
| Inventories | 17,516 | 18,496 | 17,760 | 19,090 | 18,025 | ||||||
| Accounts Receivable | 19,617 | 21,742 | 24,431 | 27,276 | 35,227 | ||||||
| Cash and Cash Equivalents | 5,683 | 7,854 | 9,408 | 12,945 | 8,196 | ||||||
| Current Assets | 50,302 | 56,369 | 60,008 | 65,682 | 67,858 | ||||||
| Total Assets | 222,449 | 230,715 | 232,999 | 228,275 | 249,728 | ||||||
Liabilities
|
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 10,492 | 11,138 | 12,544 | 14,838 | 14,897 | ||||||
| Long-term debt | 64,699 | 59,207 | 51,971 | 50,476 | 58,638 | ||||||
| Liabilities to Banks | 0.0000 | 0.0000 | 0.0000 | - | - | ||||||
| Provisions | 7,294 | 6,794 | 6,270 | - | - | ||||||
| Liabilities | 158,279 | 161,014 | 157,618 | 156,960 | 173,092 | ||||||
| Share Capital | - | - | - | - | - | ||||||
| Total Equity | 64,170 | 69,701 | 75,381 | 71,315 | 76,636 | ||||||
| Minority Interests | 306 | 312 | 306 | 300 | 175 | ||||||
| Total liabilities equity | 222,449 | 230,715 | 232,999 | 228,275 | 249,728 | ||||||
Income Statement
|
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 256,776 | 268,706 | 292,111 | 322,467 | 357,776 | ||||||
| Depreciation (total) | - | - | - | - | - | ||||||
| Operating Result | 11,987 | 13,911 | 13,193 | 7,746 | 13,743 | ||||||
| Interest Income | 3,035 | 2,907 | 2,503 | 2,287 | 2,658 | ||||||
| Income Before Taxes | 8,997 | 9,770 | 10,420 | 5,628 | 11,173 | ||||||
| Income Taxes | 2,366 | 2,569 | 2,522 | 1,463 | 2,805 | ||||||
| Minority Interests Profit | 3 | -13 | 12 | -16 | -24 | ||||||
| Net Income | 6,634 | 7,179 | 7,910 | 4,149 | 8,344 | ||||||
Per Share
Cash Flow
|
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 12,848 | 15,865 | 18,265 | 16,177 | 13,426 | ||||||
| Cash Flow from Investing Activities | -3,339 | -5,534 | -5,261 | -5,047 | -20,889 | ||||||
| Cash Flow from Financing | -7,850 | -8,155 | -11,356 | -10,516 | 2,683 | ||||||
| Decrease / Increase in Cash | 1,659 | 2,176 | 1,648 | 614 | -4,780 | ||||||
| Employees | 290,000 | 300,000 | 300,000 | - | - | ||||||
